Our Next Potential 500% Monster - Must Read

Hello subscriber. Come Monday at the first bell.

Trade Date: August, 6
Stock: E_L G O
Priced at: $0.20
Target: .46

Probiotics are activelystudied for their hypothetically helpful postion in
human health and disease. E_L G O declared recently its present in clinical
trials... and tests mean licensing endorsements... and huge revenue.

"Probiotics, in the are made of fermented foodstuffs and yogurt, have been
present in our diet for millennia. Despite their time-honored use, they were
unfamiliar in the therapeutic literature prior 1995 and not takenseriously
by the establishment until veryrecently, as these publication statistics
confirm," said Dr. Bob Hoerr, Executive Director of Enterologics.
"Innovative techniques in molecular biology are making it feasible to
enhance comprehension how probiotics interact with our bodies and the means
through which they exert their influence. We consider that Probactrix, our
E. coli M17 probiotic, likewise embraces great potential and look headfirst
to representing its potential role for discussing specific illness and
disorders through clinical trials."

Envision how big of a buzz will a company with a huge invention to save
people's life could possibly make!

Good Luck!